Lapelga vs Gastrofil

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This study is examining one-time injection of biosimilar pegfilgrastim compared with multiple injection biosimilar filgrastim post autologous hematopoietic stem cell transplantation. Study aims to compare biosimilar pegfilgrastim - LaPelga and biosimilar filgrastim -Gastrofil to see if they are similar in efficacy in terms of neutrophil engraftment, limited adverse effects, and more convenience to our patients, with potential cost savings.
Epistemonikos ID: 1fa4c06d4770b3f82f63743b5b5aeceb70810c4d
First added on: May 15, 2024